Pharmaceutical giant’s boss says 2020 deadline possible if regulators move fast

AstraZeneca’s chief executive Pascal Soriot said the company’s coronavirus vaccine could still be available by the end of the year, or early next year, despite having to pause clinical trials after a volunteer fell ill.

AstraZeneca and the University of Oxford, which are jointly developing the vaccine and testing it on 50,000 people around the world, have had to halt trials of their vaccine to investigate the “potentially unexpected illness” of one volunteer.

Continue reading…

You May Also Like

FBI chief calls Capitol attack domestic terrorism and rejects Trump’s fraud claims

Christopher Wray faces grilling from Democratic lawmakers over lead-up to 6 January…

Myanmar: tens of thousands march against military coup for second day

Large demonstration across country despite junta blocking internet access and restricting phone…

Outsourcing has eroded workers’ wages and rights | Letter

In local government, the NHS and education, there has been little protection…

Rory McIlroy ends 18-month wait with victory at Quail Hollow

Northern Irishman wins Wells Fargo Championship McIlroy’s last victory was in November…